IP
Class action claim was brought by Commission Recovery, with Marks & Clerk denying any wrongdoing | 1yr
Deborah Kirk latest in string of partner departures from Latham’s City office | 1yr
Second edition, edited by Lorne Lipkus, provides commentary on protecting brands against counterfeiting and the grey market | 1yr
German fashion house accused Chinese tech outfit of “free riding” on its reputation | 1yr
From understanding your sales channels to setting up monitoring services, Freeths experts Simon Barker and Fiona Lawson offer practical brand protection advice to keep your key assets away from fakers | 1yr
US jury awarded tech behemoth just $250 in damages in ongoing battle with medtech rival Masimo | 1yr
The long-running IP dispute related to the Nobel Prize-winning gene editing technology CRISPR rumbles on and now extends beyond ownership, write HSF lawyers Emily Bottle and Dylan Churchill | 1yr
Jenny Davies joins as a partner in Cooley’s London life sciences partnering and licensing practice | 1yr
Californian court finds ‘strong likelihood’ that ex-employee took trade secret information to benefit his own company | 1yr
Latest lawsuits in mounting patent litigation over vaccines against the two viruses | 1yr
Arrival of Tim Powell continues US firm’s European IP push | 1yr
Collaboration with online platform Created by Humans aims to protect and monetise authors’ work in age of AI | 1yr
GSK’s two patents declared invalid as both attempt to launch first RSV vaccine in UK market | 1yr
Xiaomi’s adviser Kirkland hails ‘groundbreaking’ decision to make an interim licence available ahead of FRAND trial | 1yr
US judge grants retrial as jury’s verdict is ‘against the great weight of the evidence’ | 1yr
Decision sets a precedent as it broadens the scope of lawful data use for AI training | 1yr
Boston stalwart to shutter following raids from larger rivals | 1yr
Kaplan is a leading global financial education provider through its successful Kaplan Schweser books | 1yr
Partners James Zimmerman and Scott Palmer take team to Loeb ahead of Perkins’ Beijing closure | 1yr